Cyclerion Therapeutics Inc (CYCN) support and resistance · $8.6M cap
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
This page maps Cyclerion Therapeutics Inc (CYCN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
CYCN currently screens at market cap $8.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CYCN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CYCN quote page for the session range and the stock page for the full model.
Not investment advice.